Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma

Sponsor
Johns Hopkins University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05989230
Collaborator
(none)
30
1
28

Study Details

Study Description

Brief Summary

The purpose of this single-arm trial is to determine the feasibility of emotional awareness and expression therapy (EAET) for individuals with persistent pain following orthopedic trauma. As part of this study, participants will be asked to attend weekly EAET treatment sessions and complete assessments (including pre-treatment, post-treatment, and follow-up) consisting of questionnaires and sensory testing procedures.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Emotional Awareness and Expression Therapy
N/A

Detailed Description

Orthopedic trauma, resulting in severe injuries such as multiple fractures or amputation, occurs in approximately 3 million people annually in the United States; about half of these people experience persistent pain and psychological distress (depression, anxiety, posttraumatic stress disorder [PTSD] symptoms) 6 to 12 months post injury. Pain and distress exacerbate one another, are likely to persist, and relate to disability: half of patients report substantial disability 7 years post trauma. Medical interventions such as surgery promote survival; however, there is an urgent need to develop targeted psychological interventions to treat these disabling symptoms.

Few psychological interventions are available to treat pain and distress following orthopedic trauma. Emotional Awareness and Expression Therapy (EAET) is an 8-week psychological intervention recently developed for chronic pain conditions characterized by central sensitization. EAET is unique in treating pain and mood by targeting emotion regulation processes related to traumatic life events. Such events are ubiquitous following orthopedic trauma and recent findings show that EAET results in improvements in pain and mood; thus, it may be uniquely effective to address the needs of orthopedic trauma survivors. However, there are documented barriers to implementing psychological interventions in this population, so the feasibility of EAET is unknown. The purpose of this study is to test the feasibility of delivery and assessment of EAET for orthopedic trauma survivors with persistent pain in a single-arm trial. As part of this study, participants will be asked to do the following things:

  • Attend EAET treatment with a mental health provider. Session will last around 60 minutes each.

  • Complete baseline, post-treatment, and follow-up assessments. These assessments will ask patients to complete questionnaires related to physical and emotional health, as well as receive sensory testing in order to examine pain processing. The questionnaires will take 20-25 minutes. The sensory testing procedures will take about 20 minutes.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma: A Pilot Feasibility Study
Anticipated Study Start Date :
Aug 1, 2024
Anticipated Primary Completion Date :
Dec 1, 2025
Anticipated Study Completion Date :
Dec 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Emotional Awareness and Expression Therapy

Emotional Awareness and Expression Therapy (EAET) is a non-pharmacological intervention designed to address persistent pain.

Behavioral: Emotional Awareness and Expression Therapy
The goal of EAET is to increase awareness of uncomfortable emotions that are often linked to stressful past experiences (e.g., anger, sadness, fear) and learn adaptive ways to experience and express those emotions, in a safe and controlled environment. Core treatment components include pain education, drawing associations between the experience of pain and emotion, and experiencing and expressing emotions via imaginary, in vivo, and real life exposures. EAET will be delivered via 8, 60-minute, weekly psychotherapy visits.
Other Names:
  • EAET
  • Outcome Measures

    Primary Outcome Measures

    1. Feasibility of Enrollment [24 months]

      Feasibility of enrollment will be measured by percentage of eligible patients who enroll in the study.

    2. Feasibility of Retention [24 months]

      Feasibility of retention will be measured by percentage of participants who are retained over the duration of the study.

    3. Feasibility of Recruitment [24 months]

      Feasibility of Recruitment will be measured by the enrollment of a full sample within two years of the start of the enrollment period.

    4. Percentage of patient session attendance [8 weeks]

      Percentage of patients who complete 6 of 8 total EAET sessions.

    5. Therapist Fidelity (Questionnaire developed by study team) [8 Weeks]

      Percentage of treatment fidelity across all treatment sessions (study therapist self-report using questionnaire developed by study team).

    6. Percentage of patients who indicate patient satisfaction and acceptability [8 Weeks]

      Percentage of patients who indicate treatment acceptability on the Treatment Evaluation Inventory-Short Form. This is a 9-item measure and participants respond using a 1-5 point likert scale for a possible total range of 9-45. Higher scores indicate greater satisfaction and acceptability.

    7. Feasibility of Study Assessment [1 Week]

      Measured by percent of pre-treatment assessments completed by participants.

    8. Feasibility of Study Assessment [8 Weeks]

      Measured by percent of post-treatment assessments completed by participants.

    9. Feasibility of Study Assessment [12 months]

      Measured by percent of follow-up assessments completed by participants.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • One or more acute orthopedic injuries

    • The patient sustained an orthopedic injury including, but not limited to:

    • Pelvic or acetabulum fracture

    • Open/displaced comminuted fracture of long bones

    • Upper extremity injuries with a major nerve involvement

    • Injuries with significant injuries to major blood vessels

    • Traumatic amputation of big toe, thumb, or proximal to the wrist or ankle.

    • Initial admission to the trauma or orthopedic center/service of the participating hospital OR all necessary screening and patient characteristic data available in medical record (determination based on information available at time of enrollment)

    • 18 years old or older

    • Received operative fixation for at least one acute orthopaedic injury at a participating hospital. Patients should be recruited at the time of primary injury, not revision or complication surgery

    • Average Brief Pain Inventory Score > 3/10

    • Presence of pain most days (> 3 days/week) for past three months

    Exclusion Criteria:
    • peri-prosthetic fractures of the femur (regardless of etiology)

    • non-ambulatory due to an associated spinal cord injury

    • non-ambulatory pre-injury

    • currently pregnant

    • moderate or severe traumatic brain injury (TBI), as evidenced by intracranial hemorrhage present on admission CT

    • major amputation(s) of the upper or lower extremities

    • non-English speaking

    • Likely to have severe problems with maintaining follow-up for any of the following reasons:

    • The patient has been diagnosed with a severe psychiatric conditions

    • The patient has current alcohol and/or drug addiction based on medical record or patient self-report.

    • The patient is intellectually challenged without adequate family support

    • The patient lives outside the hospital's catchment area

    • The patient follow-up is planned at another medical center

    • The patient is a prisoner

    • The patient is homeless

    • Other

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Johns Hopkins University

    Investigators

    • Principal Investigator: Rachel Aaron, PhD, Johns Hopkins University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Johns Hopkins University
    ClinicalTrials.gov Identifier:
    NCT05989230
    Other Study ID Numbers:
    • IRB00277255
    First Posted:
    Aug 14, 2023
    Last Update Posted:
    Aug 14, 2023
    Last Verified:
    Aug 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 14, 2023